Your browser doesn't support javascript.
loading
Therapeutic activity of an inhaled potent SARS-CoV-2 neutralizing human monoclonal antibody in hamsters.
Piepenbrink, Michael S; Park, Jun-Gyu; Oladunni, Fatai S; Deshpande, Ashlesha; Basu, Madhubanti; Sarkar, Sanghita; Loos, Andreas; Woo, Jennifer; Lovalenti, Phillip; Sloan, Derek; Ye, Chengjin; Chiem, Kevin; Bates, Christopher W; Burch, Reuben E; Erdmann, Nathaniel B; Goepfert, Paul A; Truong, Vu L; Walter, Mark R; Martinez-Sobrido, Luis; Kobie, James J.
Afiliación
  • Piepenbrink MS; Department of Medicine, Division of Infectious Diseases, University of Alabama at Birmingham, Birmingham, AL, USA.
  • Park JG; Texas Biomedical Research Institute, San Antonio, TX, USA.
  • Oladunni FS; Texas Biomedical Research Institute, San Antonio, TX, USA.
  • Deshpande A; Department of Microbiology, University of Alabama at Birmingham, Birmingham, AL, USA.
  • Basu M; Department of Medicine, Division of Infectious Diseases, University of Alabama at Birmingham, Birmingham, AL, USA.
  • Sarkar S; Department of Medicine, Division of Infectious Diseases, University of Alabama at Birmingham, Birmingham, AL, USA.
  • Loos A; Aridis Pharmaceuticals, San Jose, CA, USA.
  • Woo J; Aridis Pharmaceuticals, San Jose, CA, USA.
  • Lovalenti P; Aridis Pharmaceuticals, San Jose, CA, USA.
  • Sloan D; Aridis Pharmaceuticals, San Jose, CA, USA.
  • Ye C; Texas Biomedical Research Institute, San Antonio, TX, USA.
  • Chiem K; Texas Biomedical Research Institute, San Antonio, TX, USA.
  • Bates CW; Department of Medicine, Division of Infectious Diseases, University of Alabama at Birmingham, Birmingham, AL, USA.
  • Burch RE; Department of Medicine, Division of Infectious Diseases, University of Alabama at Birmingham, Birmingham, AL, USA.
  • Erdmann NB; Department of Medicine, Division of Infectious Diseases, University of Alabama at Birmingham, Birmingham, AL, USA.
  • Goepfert PA; Department of Medicine, Division of Infectious Diseases, University of Alabama at Birmingham, Birmingham, AL, USA.
  • Truong VL; Department of Microbiology, University of Alabama at Birmingham, Birmingham, AL, USA.
  • Walter MR; Aridis Pharmaceuticals, San Jose, CA, USA.
  • Martinez-Sobrido L; Department of Microbiology, University of Alabama at Birmingham, Birmingham, AL, USA.
  • Kobie JJ; Texas Biomedical Research Institute, San Antonio, TX, USA.
Cell Rep Med ; 2(3): 100218, 2021 03 16.
Article en En | MEDLINE | ID: mdl-33649747
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Tratamiento Farmacológico de COVID-19 / Anticuerpos Monoclonales Límite: Animals / Female / Humans / Male / Middle aged Idioma: En Revista: Cell Rep Med Año: 2021 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Estados Unidos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Tratamiento Farmacológico de COVID-19 / Anticuerpos Monoclonales Límite: Animals / Female / Humans / Male / Middle aged Idioma: En Revista: Cell Rep Med Año: 2021 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Estados Unidos